Surgical Outcomes In Gastric Cancer

In their meta-analysis, Treadwell and colleagues reviewed post–gastric bypass complications in six studies that included a total of 131 patients. No operation related hospital deaths occurred, but one death occurred in a child 9 months after gastric bypass who contracted severe Clostridium difficile colitis and experienced multisystem organ failure. Shock, pulmonary embolism, postoperative bleeding, severe malnutrition, and bowel obstruction occurred postoperatively, but because of variability in the way these complications were reported, the authors of the meta-analysis were unable to calculate actual incidences. Protein-calorie malnutrition and micronutrient deficiency were also reported, but their overall incidence in adolescents was unclear

Post-Operative Nausea and Vomiting (PONV) is defined as any nausea, retching or vomiting occurring during the first 24 hours after surgery (Oxford Journals). It is an uncomfortable and unpleasant experience for the patient and can adversely affect the post recovery outcome by causing dehydration, electrolyte imbalance, aspiration, wound dehiscence, increasing length of stay (LOS), unanticipated admission, and increased healthcare costs, not to mention a top concern and great dissatisfier for the patient (JPN, Hodgens). Since approximately 30% of all post-operative patients

The average age at the time of diagnosis (N=12.52) with a (SD=3.64) and the mean number of years since completion of last protocol (N=12) with a (SD=3.28). The participant sample is primarily Caucasian (N=200,56%), with the representative of African American (N=93,26%), Asian (N=18,5%), Hispanic (N=22,6%), other (N=19,5%) backgrounds (one missing data). Initial cancer diagnoses were: solid and soft tissue tumors (Osteosarcoma, Ewing’s sarcoma, Wilms tumor; N=225,63%), lymphomas (Hodgkin’s, Non-Hodgkin’s; N=47,13%), leukemias (ALL-Acute Lymphocytic, AML-Acute Myeloid, CML- Chronic Myelogenous; N=34,9%), central nervous system tumors (N=47,13%).

In 2010 and 2011 inclusive, approximately 2.4 million hospitalisations within Australia were for the purpose of surgery. Of the approximated 2.4 million, 1.9 million of these were classified as elective admissions (Australian Institute of Health and Welfare 2010-11). Australia is shown to have an ageing population, (Australian Bureau of Statistics. 2006) which indicates an increasing percentage of patients undertaking surgery are elderly with numerous comorbidities. In considering these it pre-operative assessment as a means of risk management prior to surgery seeks to reduce the potential probability of perioperative complications.

BACKGROUND Whether regional anesthesia is associated with tumor-free and long-term survival is controversial. Here, we focused on whether epidural anesthesia affects the long-term survival of gastric cancer patients after surgery. MATERIAL AND METHODS We obtained the records of 273 patients undergoing gastric cancer surgery between August 2006 and December 2010. All patients received elective surgery, and the end-point was death. The general anesthesia group comprised 116 patients and the epidural-supplemented group comprised 157 patients. The results were analyzed using a multivariable model to determine the relationship between epidural use and long-term survival. RESULTS No obvious association was detected between epidural use and long-term

Gallbladder cancer (GBC), though a rare neoplsam, is a highly aggressive and fatal disease with wide geographical, ethnic, and gender specific variations in its incidence. As there are no specific signs or symptoms or reliable sensitive markers, the cancer is usually diagnosed at advance stages and the outcome is dismal. Patients with lesions confined to the gallbladder mucosa have a 32% five year survival rate, while patients with more advanced lesions have only a 10% chance of 5-year survival (Lazcano-Ponce et al. 2001). Neither radiation nor conventional chemotherapy has been shown to significantly improves survival or quality of life for GBC patients. Early diagnosis can have significant curative impact with surgery as the only therapeutic

Gastric cancer is one of the second most common cancers all over the world with high morbidity and poor prognosis (Peter and Beglinger, 2007).Though it

The standard way of thinking about the topic stomach cancer also known as gastric cancer has it that gastric cancer doesn’t have a high death rate. Rather than the death rate of an individual dying from alcohol, drugs, suicide or even someone who’s been in a car accident. However, those may be the main reason of death but in this case it has been know that gastric cancer is now stating to have more and more individuals being diagnosed with it.

Surgery is broken up into the different types and what exactly they are used for and what stage of cancer they are used in. There are many different types of surgery, from using it to diagnose cancer, to using it to restore a patient’s look after being cured. Mainly the surgery used by doctors to help patients with cancer is to help along the other treatments, and is rarely used by itself but when it is, it’s called curative surgery. Curative surgery is used when there is very little cancer and it can all be removed through surgery, and this is very little of the time as it rarely happens. The main use of surgery in cancer treatment is to diagnose and to see how far the cancer has spread. The diagnostic surgery is really the only way to be completely sure what kind of cancer it is and how far along it is. In diagnostic surgery they take a small tissue sample and send it through direct testing. To go along with diagnostic surgery there is staging surgery to find out what stage the cancer is, these two surgeries usually go hand-in-hand. Surgery can also be used to take out parts of cancer that have been shrunk by other types of treatment, speeding up the treatment process and bringing the cancer treatment to later stages sooner. Surgery is often used in conjunction with all types of treatments to move them along, or make sure they will work

Background Sleeve gastrectomy (SG) is an alternative to gastric bypass and laparoscopic adjustable gastric banding (GB). Methods From January 2004 to January 2006, 111 patients with a follow-up longer than 24 months were prospectively followed. Three treatment groups were defined. Sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of GB.

Pre- and post-operative Patient Reported Outcomes Measures (PROMs) are being used with increasing frequency to measure the severity of a patient’s symptoms and level of function. They can be important tools in assessing a patient’s suitability for surgery, expected outcome and post-operative recovery. Although their use derives helpful clinical data, not all clinicians have adopted their use into their busy clinical practice.

Patient factors include age, gender, education, ethnicity, socio-economic status and how much patient knows about cancer and cancer symptoms. Age appears to be the major determinants of cancer survival. Cancer survival rate for almost all types of cancers decrease significantly with age. Research has shown that elderly patients generally do not receive the same standard of treatments and care, as compared to younger patients. Elderly patients are also reported to be less likely to receive surgery and the most effective treatment than younger people irrespective of the co-morbidities. This is because healthcare professionals tend to make decisions based on the assumptions that older patients will not be able to cope with certain treatments

Cholangiocarcinoma is a rare malignancy that originates from the epithelial lining of the biliary ductal system. It constitutes around 3% of all gastrointestinal malignancies. There is a high variability in the estimated incidence of cholangiocarcinoma across the world, with the highest age standardized incidence rate in the northeast provinces of Thailand (113 per 100,00 person-year) as compared to the western hemisphere (0.5-1.5 per 100,00 person-year). Cholangiocarcinomas are resistant to chemotherapy and radiotherapy and surgical resection constitutes the definitive form of therapy. Poor prognosis and low 5 year survival is almost universal to theses tumors,

Nevertheless, this treatment has some limiting factors that prevent achieving the ultimate aim of treatment for cancer. For surgery, it can’t be done for cancer that stays deep beneath the abdomen such as pancreas and act to remove local cancer cell (Poppel, Deroo & Joniau, 2003). In addition, the most limiting factor is the surgery cannot deal with metastasis cancer. Often the cancer that grow in breast as example, later grow and move to other parts of the body which continue spread to whole body. Thus, even if surgery is already done the probability of cancer still exist in patients’ boy is high. For this reason, the surgery always suggested for small cancers and accompanied with the chemotherapy and radiotherapy. The healthy cells also

The patient is an 84-year-old gentleman who presented to the ED because the J-tube had fallen out. The patient had a subtotal gastrectomy Roux-en Y and gastrojejunostomy with D tube adenoidectomy and placement of jejunostomy tube on 12/14/2016 for gastric tumor. The patient was discharged to a rehabilitation and presented because the jejunostomy tube had dislodged. It actually had been pulled out the morning of presentation. The patient was clinically stable and was admitted inpatient. The patient was already tolerating oral feedings and basically stayed overnight in the hospital and was discharged. We attempted to request an outpatient order on this patient and never received it, therefore the admission is